Connect with us

Technology

MedAdvisor Solutions Launches Telehealth Service on MedAdvisor Patient App, Further Enhancing Access to Care

Published

on

Patients can now book virtual provider consultations within the App

MELBOURNE, Australia, Nov. 6, 2024 /PRNewswire/ — MedAdvisor Solutions, a global leader in pharmacy-driven patient engagement solutions, announced today that new Telehealth functionality is now available within the MedAdvisor App and is already being utilised by patients. Access to telehealth services was ranked as the 3rd most desirable feature by pharmacists, based on feedback from our extensive network of pharmacy partners1. Telehealth access via the App simplifies the patient healthcare journey, allowing patients to consult with providers and manage their prescriptions from anywhere, at any time.

This new feature in the MedAdvisor App allows patients to book virtual consultations with providers and receive eScripts following the consultation. The App also allows patients to pre-order medications from their preferred pharmacy and receive renewal reminders as needed.

The launch reflects MedAdvisor Solutions commitment to meet the evolving needs of patients and pharmacies across Australia, where more than 95,000 practitioners use Telehealth and 23% of appointments occur via Telehealth2. By making prescriptions, medication information and health services available through the MedAdvisor App patients can take a more active role in their healthcare journey, enhancing adherence and improving outcomes.

The feature allows for more seamless communication between patients, pharmacists, and providers, ultimately improving care coordination and eliminating barriers to medication adherence, such as geographic or time constraints.

“Providing seamless access to Telehealth services is a natural progression for the MedAdvisor app, providing a comprehensive resource for patients’ healthcare needs,” said Wayne Marinoff, President ANZ of MedAdvisor Solutions. “By enabling virtual consultations and eScript functionality, we are not only enhancing patient engagement and satisfaction, but also helping pharmacies streamline their operations and maintain strong patient relationships.”

To access the new Telehealth feature, patients can download the MedAdvisor App from the App Store or Google Play for free. After logging in, patients will have access to a wide range of healthcare services, including the ability to book virtual consultations with healthcare providers and receive eScripts directly within the App. The MedAdvisor App streamlines the entire healthcare journey, allowing patients to manage prescriptions, consult with professionals, and access medication reminders—all in one convenient platform.

Access to telehealth within the App aligns with the company’s commitment to enhancing access to care for patients across the country. Last year, MedAdvisor Solutions was chosen as the preferred software provider for the Expanded Scope of Practice initiatives. Today, more than 84,000 patients have received 88,400 services across 3,640 pharmacies. Additionally, 84% of pharmacies report being satisfied with MedAdvisor Solutions’ ability to help them expand the scope of health services in their pharmacy.1 By continuing to collaborate with our pharmacy partners and evolve our platform, MedAdvisor Solutions is helping to drive the future of patient-centric care.

About MedAdvisor Solutions
MedAdvisor Solutions is a global leader of pharmacy-driven patient engagement solutions that provide individualized patient experiences to simplify the patient medication journey. Our solutions utilise an empathetic, data-driven approach to engagement and an innovative, patient-centric digital experience that empower the pharmacy of the future and inspire lasting behaviour change. MedAdvisor Solutions works with over 37,000 pharmacies across the US, Australia & New Zealand to deliver our solutions to help patients take their medication safely and effectively.

In Australia, MedAdvisor Solutions has connected nearly 4 million patients through more than 95% of Australian pharmacies. MedAdvisor Solutions is on track to become one of the largest players to aid in the global transformation of the pharmacy of the future through digital patient engagement solutions. In 2018 and 2020, MedAdvisor Solutions was recognized in the AFR Fast 100 and in 2022, 2023 and 2024 received the Retail Excellence Award (REX) for Technology & Automation from Drug Store News.

www.medadvisorsolutions.com 

12023 internal MedAdvisor research of 459 pharmacists across 451 pharmacies in Australia
2Australian Government Department of Health and Aged Care, 6 October 2023, Does using telehealth affect our healthcare?

Logo – https://mma.prnewswire.com/media/2507736/MedAdvisor_Solutions_Logo.jpg

View original content:https://www.prnewswire.com/apac/news-releases/medadvisor-solutions-launches-telehealth-service-on-medadvisor-patient-app-further-enhancing-access-to-care-302297006.html

SOURCE MedAdvisor Solutions

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Duoning Biotech announced strategic partnership with Branca Bunús to promote the next generation of transfection reagents

Published

on

By

SHANGHAI, Nov. 5, 2024 /PRNewswire/ — Duoning Biotechnology Group (“Duoning”) announced a strategic partnership agreement with Branca Bunús Ltd. (“Branca Bunús”). Under this agreement, the two companies will collaborate on the development, optimization, and application of transfection reagents, with the goal of providing  biopharmaceutical customers with innovative transfection reagents through resource sharing, thereby enhancing the efficiency of biopharmaceutical development in upstream bioprocess.

Branca Bunús is a gene delivery technology company based in Ireland, specializing in the development of safe gene delivery vectors and effective transfection reagents derived from unique cationic polymer materials. Guided by a product development philosophy that emphasizes high efficiency, biocompatibility, and significant clinical and industrial application value, Branca Bunús has created the BrPERfect® series of transfection reagents. The company also offers supporting services, including the development of targeted gene delivery vectors and directional optimization. As a well-established one-stop bioprocess solution provider in China, Duoning Biotech’s offerings encompass the entire bioprocess workflow, from upstream cell culture to downstream filtration and purification. Additionally, Duoning Biotech provides services such as media production, process optimization, and validation testing.

After the cooperation is established, Branca Bunús will be responsible for the research, development, and performance enhancement of transfection reagents. This includes scientific research applications involving DNA, siRNA, and mRNA transfection, as well as the production of recombinant proteins, AAV, and LV based on the transient transfection of CHO and HEK 293 cells. Duoning will leverage its established sales network and collaborative sales strategy for upstream process products to comprehensively promote this solution. Additionally, both parties will form a specialized research and marketing team to optimize the transient transfection process by examining the interaction principles of transfection reagents and cell culture media. They will also conduct market research to develop a comprehensive solution for the application of transfection reagents.

Hongfeng Gu, Vice President of Duoning, stated, “Branca Bunús is an emerging biotechnology company that has developed a leading hyperbranched polymer gene delivery vector platform, founded by Professor Wenxin Wang. We are honored to collaborate with companies that possess core technologies. The BrPERfect® series of transfection reagents from Branca Bunús, combined with Duoning’s cell culture media, bioreactors, and other products, will offer customers more comprehensive upstream bioprocessing solutions.”

Dr. Zhonglei He, Chief Technology Officer of Branca Bunús, stated, “The significant contribution of Duoning to the rapid development of the biotechnology market is evident to all. We are honored to collaborate with Duoning, particularly in its one-stop bioprocessing solutions. Our goal is to provide efficient and stable transfection reagent products and process support, ensuring timely and high-quality products and services for various R&D and production applications, including transient protein production and screening in downstream processes, stem cell enhancement, and the production of diverse viral vectors through transient transfection.”

About Duoning

Shanghai Duoning Biotechnology Co., Ltd. (“Duoning”) is a leading one-stop bioprocess solutions provider in China, committed to offering products and services required for the discovery, development and commercialization production of biologics, including reagents, consumables, instruments, equipment, and validation services. Leveraging our integrated bioprocess system, we empower our partners to achieve effective, reliable, lower-cost and higher-quality biologics production processes. For more information, please visit: www.duoningbio.com/en

For media inquiries, please contact: PR@duoningbio.com 

About Branca Bunús

Branca Bunús is an emerging Irish biotechnology company specializing in innovative gene delivery technologies. Leveraging over a decade of research by its founding technical team, the company focuses on the development and production of advanced gene delivery vectors and transfection reagents. Branca Bunús aims to provide cost-effective, high-yield transient transfection solutions, along with supporting services such as targeted gene delivery vector development and directional optimization. The company is dedicated to transforming groundbreaking discoveries into life-changing practical applications. To learn more, please visit: http://brancabunus.com

View original content:https://www.prnewswire.com/news-releases/duoning-biotech-announced-strategic-partnership-with-branca-bunus-to-promote-the-next-generation-of-transfection-reagents-302297073.html

SOURCE Duoning

Continue Reading

Technology

UnionPay International joins forces with industry players to optimize payment experience for international visitors to China

Published

on

By

Global UnionPay Cards Now Support Weixin Pay and Alipay

SHANGHAI, Nov. 5, 2024 /CNW/ — UnionPay International (UPI) announced that Alipay and Weixin payments are fully enabled for UnionPay cards issued outside China’s mainland, providing more diversified, convenient and inclusive payment options for inbound travelers to China. The collaboration with Weixin Pay is supported through the Industrial and Commercial Bank of China (ICBC).

In order to further optimize payment services, UnionPay launched Project Excellence 2024 in March, joining hands with various industry stakeholders to build a convenient, inclusive, and accessible payment ecosystem. This collaboration is the latest achievement of the Project. From now on, international travelers to China can download Alipay or Wexin applications, link their local UnionPay cards, and enjoy the same convenience of QR payments as the Chinese users do.

This innovative payment method will provide more convenience for inbound visitors to pay in China: No service fee will apply throughout the payment process as initial promotion, which enables users to make payments as if they were at home. Online and offline use cases are covered, including F&B, accommodation, transit, sightseeing, shopping and entertainment. The new method supports consumer-presented, merchant-presented, in-app payment and ETC, which removes the payment barriers for users who are travelling, working or living in China. The new enablement is easy to use, as cardholders only need to enter the UnionPay card information required, and complete the linking process once the card issuer performs the authentication.

This collaboration manifests UPI’s stepped-up efforts to work with other industry stakeholders to promote payment interoperability and develop a sustainable business model. It will help to further bridge the differences in payment preference between China and the rest of the world, facilitate the country’s high-standard opening up.

UnionPay’s international business has become increasingly localized in the past few years, and more and more consumers outside China are enjoying the convenient services brought by UnionPay. Over 250 million UnionPay cards have been issued in 83 countries and regions outside China’s mainland, which can be used for payments in 183 countries and regions. UnionPay has also launched SplendorPlus, a new card product tailored to international visitors to China. The themed card, which comes with diverse benefits and special merchant offers in China, has proven to be highly popular.

 

View original content:https://www.prnewswire.com/news-releases/unionpay-international-joins-forces-with-industry-players-to-optimize-payment-experience-for-international-visitors-to-china-302296568.html

SOURCE UnionPay International

Continue Reading

Technology

Horizons Shines at CIIE 2024 with Global Leader Recognition in G2’s Fall 2024 Reports

Published

on

By

SHANGHAI, Nov. 5, 2024 /PRNewswire/ — Horizons, a leading global Employer of Record (EOR) provider, proudly launches its latest Global HR Strategy at the 2024 China International Import Expo (CIIE) from November 5 to 10 in Shanghai. Under the theme “Talent Without Borders, Vision Without Limits,” Horizons will showcase its commitment to empowering a borderless workforce and present its innovative SaaS HR platform, designed to enhance HR compliance, simplify payroll, and streamline employee and contractor payment for businesses worldwide..

At CIIE, Horizons will demonstrate how advancements in technology, including AI, big data, and cloud computing, are reshaping HR management. The event will also highlight Horizons’ strategic collaborations with other innovators in the sector to support both global and Chinese enterprises in expanding their workforces across borders.

Coinciding with its presence at CIIE, Horizons has been recognized as a Global Leader in G2‘s Fall 2024 Reports across multiple categories in Global Employment Platforms (GEP) and Contractor Management. This recognition underscores Horizons’ dedication to a full range of global hiring solutions, covering both contractors and employees.

Horizons Fall 2024 G2 Recognitions

Leader in Mid-Market EMEA Contractor ManagementLeader in EMEA Global Employment Platforms (GEP)Leader in Mid-Market Global Employment Platforms (GEP) – Recognized for Easiest Admin and Easiest To Do Business WithLeader in Global Employment Platforms (GEP) – Recognized for Easiest AdminLeader in Small-Business Global Employment Platforms (GEP)Users Love Us: Awarded for consistently high customer satisfaction ratings

“Horizons’ mission is to build solutions that empower the borderless workforce, and our vision is to create equal opportunity for all,” said Antoine Boquen, Horizons’ CEO and Co-founder. “Our G2 recognition across multiple categories, and presence at CIIE, reflect our continued dedication to businesses of all sizes in their global hiring journey.  We firmly believe that location should be no barrier to businesses hiring the best talent, and professionals finding the best workplace.

About Horizons

Horizons is a leading global Employer of Record (EOR), transforming how businesses hire internationally. Our innovative platform simplifies global hiring by managing compliance, payroll, and payments through established local infrastructure in over 100 countries. Trusted by over 3,000 businesses, Horizons enables companies of all sizes to hire overseas talent quickly and cost-effectively.

Learn more: https://joinhorizons.com/

Contacts

Lily Zhang, Digital Marketing Manager at Horizons

lily.zhang@horizons.com 

View original content:https://www.prnewswire.com/news-releases/horizons-shines-at-ciie-2024-with-global-leader-recognition-in-g2s-fall-2024-reports-302296380.html

SOURCE Horizons

Continue Reading

Trending